Strides arm and its partner get USFDA nod for hypokalemia treatment drug

The United States Food and Drug Administration (USFDA) has approved the product in the strengths of 10 mEq (750 mg), 15 mEq (1,125 mg), and 20 mEq (1,500 mg), Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2CMxfBi